Publications by authors named "Robert Rawson"

Claim this Profile
T
The Prognostic Significance of Tumoral Melanosis.
Alison J Potter, Peter M Ferguson, Serigne N Lo, Tasnia Ahmed, Robert V Rawson

J Cutan Pathol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Analysis Reveals Dynamic Changes in Histopathologic Features in Responders to Neoadjuvant Treatment in a Stage III BRAF-Mutant Melanoma Cohort.
Jorja Braden, Alison Potter, Robert V Rawson, Nurudeen A Adegoke, Serigne N Lo

Mod Pathol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cartilage Resection in the Surgical Management of Ear Melanoma.
Elan Novis, Joyce Tan, Danielle Vignati, Terence Wong, Robert V Rawson

Ann Surg Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.
Georgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan, Yizhe Mao, Inês Pires da Silva, Robert V Rawson

Nat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.
Li Zhou, Milton Jose Barros E Silva, Edward Hsiao, Zeynep Eroglu, Shahneen Sandhu, Robert V Rawson

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
Christian U Blank, Minke W Lucas, Richard A Scolyer, Bart A van de Wiel, Alexander M Menzies, Robert V Rawson

N Engl J Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.
Lisanne P Zijlker, Henry Chen, Andrew J Spillane, Maria Gonzalez, Thomas E Pennington, Robert Rawson

Ann Surg Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter-rater concordance of basal cell carcinoma subtypes: influences on reporting format and opportunities for further classification modifications.
Nigel G Maher, Natasha Prosser, Karina Aivazian, Andrew J Colebatch, Peter M Ferguson, Robert V Rawson

Pathology· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinical correlates of HER3 expression highlights its potential role as a therapeutic target in melanoma.
Eva R Shteinman, Ismael A Vergara, Robert V Rawson, Serigne N Lo, Naoyuki Maeda

Pathology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case-control study.
Bruna Melhoranse Gouveia, Giuliana Carlos, Andreanne Wadell, Christoph Sinz, Tasnia Ahmed, Robert V Rawson

J Eur Acad Dermatol Venereol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.
Irene L M Reijers, Disha Rao, Judith M Versluis, Alexander M Menzies, Petros Dimitriadis, Robert V Rawson

J Exp Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanomas in children and adolescents: Clinicopathologic features and survival outcomes.
Mary-Ann El Sharouni, Robert V Rawson, Alison J Potter, Elizabeth C Paver, James S Wilmott

J Am Acad Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics.
Robert V Rawson, Eva R Shteinman, Sameera Ansar, Ismael A Vergara, John F Thompson

Pathology· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.
Felicity Newell, Peter A Johansson, James S Wilmott, Katia Nones, Vanessa Lakis, Robert V Rawson

Cancer Discov· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis.
Kazi J Nahar, Felix Marsh-Wakefield, Robert V Rawson, Tuba N Gide, Angela L Ferguson

JCI Insight· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites.
Jordan W Conway, Robert V Rawson, Serigne Lo, Tasnia Ahmed, Ismael A Vergara

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultrathick melanomas (≥15 mm in thickness).
Mary-Ann El Sharouni, Robert V Rawson, Vigfús Sigurdsson, Arjen J Witkamp, Carla H van Gils

J Am Acad Dermatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centre.
Alison J Potter, Andrew J Colebatch, Robert V Rawson, Peter M Ferguson, Wendy A Cooper

Pathology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Amanda E Yung, Gareth Crouch, Alexander H R Varey, Serigne Lo, Michael S Elliott, Robert Rawson

Ann Surg Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi.
Andrew J Colebatch, Chandra Adhikari, Russell J Diefenbach, Robert V Rawson, Peter M Ferguson

Am J Surg Pathol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex management of lentigo maligna in the setting of chrysiasis, argyriasis, and tattoo using in vivo reflectance confocal microscopy.
Arthur Martin, Bruna Melhoranse Gouveia, Robert Rawson, Pascale Guitera

J Dermatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.
Irene L M Reijers, Alexander M Menzies, Alexander C J van Akkooi, Judith M Versluis, Noëlle M J van den Heuvel, Robert V Rawson

Nat Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.
Irene L M Reijers, Robert V Rawson, Andrew J Colebatch, Elisa A Rozeman, Alex M Menzies

JAMA Surg· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary cutaneous CD8+ aggressive epidermotropic T-cell lymphoma mimicking pyoderma gangrenosum.
Akshay Flora, Matthew Gibson, Christopher Toon, Robert Rawson, Patricia Lowe

Indian J Dermatol Venereol Leprol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.
Richard A Scolyer, Victoria Atkinson, David E Gyorki, Duncan Lambie, Sandra O'Toole, Robert V Rawson

Pathology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis